Patient Name : Ms.
BHUVANA VASUDEVA RAO Collected : 26/Mar/2025 06:50AM
Age/Gender : 49 Y 10 M 29 D /F Received : 26/Mar/2025 01:29PM
UHID/MR No : APJ1.0011820840 Reported : 26/Mar/2025 03:36PM
Visit ID : DRCHOPV5267 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : ARKEESWARAR COLONY,Chennai
DEPARTMENT OF IMMUNOLOGY
FREE AND TOTAL THYROID PROFILE (T3,T4, FT3, FT4,TSH)
Test Name Result Unit Bio. Ref. Interval Method
TRI-IODOTHYRONINE (T3, TOTAL) , 143 ng/dL 84.6-202 ECLIA
SERUM
Test Name Result Unit Bio. Ref. Interval Method
THYROXINE (T4, TOTAL) , SERUM 10.9 µg/dL 5.12-14.06 ECLIA
Test Name Result Unit Bio. Ref. Interval Method
THYROID STIMULATING HORMONE 5.180 µIU/mL 0.270-4.20 ECLIA
(TSH) , SERUM
Comment:
TSH is a glycoprotein hormone secreted by the anterior pituitary. TSH is a labile hormone & is secreted in a pulsatile manner
throughout the day and is subject to several non-thyroidal pituitary influences. Significant variations in TSH can occur with
circadian rhythm, hormonal status, stress, sleep deprivation, caloric intake, medication & circulating antibodies.
It is important to confirm any TSH abnormality in a fresh specimen drawn after ~ 3 weeks before assigning a diagnosis, as the
cause of an isolated TSH abnormality.
For Pregnant Women Bio Ref Range for TSH in µIU/mL
First trimester 0.33 – 4.59
Second trimester 0.35 – 4.10
Third trimester 0.21 – 3.15
Test Name Result Unit Bio. Ref. Interval Method
FREE T3 (FT3) , SERUM 3.37 pg/mL 2.42-4.36 ECLIA
Comment:
Elevated concentrations of FT3 occur in Grave’s disease and most other classical causes of hyperthyroidism.Decreased
concentrations occur in primary hypothyroid diseases such as Hashimoto thyroiditis and neonatal hypothyroidism or secondary
hypothyroidism due to defects at the hypothalamohypophyseal level. It may decrease by ≤25% in healthy older persons while FT4
remains normal.
For pregnant Bio Ref Range for Free T3 (FT3)
females in pg/mL
Page 1 of 2
SIN No:IM09457940
This test has been performed at Apollo Health & Lifestyle Ltd, Central Reference Laboratory, Chennai
Patient Name : Ms.BHUVANA VASUDEVA RAO Collected : 26/Mar/2025 06:50AM
Age/Gender : 49 Y 10 M 29 D /F Received : 26/Mar/2025 01:29PM
UHID/MR No : APJ1.0011820840 Reported : 26/Mar/2025 03:36PM
Visit ID : DRCHOPV5267 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : ARKEESWARAR COLONY,Chennai
DEPARTMENT OF IMMUNOLOGY
FREE AND TOTAL THYROID PROFILE (T3,T4, FT3, FT4,TSH)
First trimester 2.46 – 3.89
Second trimester 2.09 – 3.55
Third trimester 2.01 – 3.27
Test Name Result Unit Bio. Ref. Interval Method
FREE T4 (FT4) , SERUM 1.53 ng/dL 0.95-1.57 ECLIA
Comment:
FT4 gives corrected values in patients in whom the total T4 is altered on account of changes in serum proteins or in binding
sites.Monitoring restoration to normal range is the only laboratory criterion to estimate appropriate replacement dose of
levothyroxine because 6–8 weeks are required before TSH reflects these changes. FT4 assays are prone to inaccurate readings in
pregnant women. Anticonvulsant drug therapy (particularly phenytoin) may result in decreased FT4 levels due to an increased
hepatic metabolism and secondarily to displacement of hormone from binding sites.
For pregnant Bio Ref Range for Free T4 (FT4)
females in ng/dL
First trimester 0.94 – 1.52
Second trimester 0.75 – 1.32
Third trimester 0.65 – 1.24
*** End Of Report ***
Page 2 of 2
SIN No:IM09457940
This test has been performed at Apollo Health & Lifestyle Ltd, Central Reference Laboratory, Chennai
Patient Name : Ms.BHUVANA VASUDEVA RAO Collected : 26/Mar/2025 06:50AM
Age/Gender : 49 Y 10 M 29 D /F Received : 26/Mar/2025 01:29PM
UHID/MR No : APJ1.0011820840 Reported : 26/Mar/2025 03:36PM
Visit ID : DRCHOPV5267 Status : Final Report
Ref Doctor : Dr.SELF Client Name : PUP 24X7_CREDIT
IP/OP NO : Center location : ARKEESWARAR COLONY,Chennai
TERMS AND CONDITIONS GOVERNING THIS REPORT
1. Reported results are for information and interpretation of the referring doctor or such other medical professionals,
who understandreporting units, reference ranges and limitation of technologies.Laboratories not be responsible for any
interpretation whatsoever.
2. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the
verifications of parrticulars have been confirmed by the patient or his / her representative at the point of generation of said specimen.
3. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
4. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies.
5. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
6. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only.
SIN No:IM09457940
This test has been performed at Apollo Health & Lifestyle Ltd, Central Reference Laboratory, Chennai
